Exploration of Q-Marker of Rhubarb Based on Intelligent Data Processing Techniques and the AUC Pooled Method.

AUC-pooled method Q-marker intelligent data processing techniques rhein rhubarb

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 29 01 2022
accepted: 21 02 2022
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

Rhubarb, as a traditional Chinese medicine, has several positive therapeutic effects, such as purging and attacking accumulation, clearing heat and purging fire, cooling blood, and detoxification. Recently, Rhubarb has been used in prescriptions for the prevention and treatment of COVID-19, with good efficacy. However, the exploration of effective quantitative approach to ensure the consistency of rhubarb's therapeutic efficacy remains a challenge. In this case, this study aims to use non-targeted and targeted data mining technologies for its exploration and has comprehensively identified 72 rhubarb-related components in human plasma for the first time. In details, the area under the time-concentration curve (AUC)-pooled method was used to quickly screen the components with high exposure, and the main components were analyzed using Pearson correlation and other statistical analyses. Interestingly, the prototype component (rhein) with high exposure could be selected out as a Q-marker, which could also reflect the metabolic status changes of rhubarb anthraquinone in human. Furthermore, after comparing the metabolism of different species, mice were selected as model animals to verify the pharmacodynamics of rhein. The

Identifiants

pubmed: 35387347
doi: 10.3389/fphar.2022.865066
pii: 865066
pmc: PMC8979112
doi:

Types de publication

Journal Article

Langues

eng

Pagination

865066

Informations de copyright

Copyright © 2022 Chen, Jiang, Zhu, Yang, Liu, Zhu and Wu.

Déclaration de conflit d'intérêts

Author MZ is employed by company MassDefect Technologies. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Electrophoresis. 2021 Dec 11;:
pubmed: 34894354
Phytomedicine. 2018 May 15;44:109-116
pubmed: 29426601
Anal Bioanal Chem. 2020 Nov;412(28):7891-7897
pubmed: 32888045
J Chromatogr A. 2010 Nov 5;1217(45):7144-52
pubmed: 20889158
J Pharm Biomed Anal. 2019 Sep 10;174:89-103
pubmed: 31158610
Phytomedicine. 2018 May 15;44:204-211
pubmed: 29551645
Arch Toxicol. 2021 Jan;95(1):117-133
pubmed: 33150952
Drug Metab Dispos. 2016 Jun;44(6):800-8
pubmed: 27013399
Front Pharmacol. 2020 Apr 16;11:425
pubmed: 32372953
Pharmacol Res. 2020 Sep;159:104935
pubmed: 32464328
Phytochemistry. 2017 Jul;139:72-80
pubmed: 28426978
Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):875-94
pubmed: 17125407
Front Pharmacol. 2021 Nov 29;12:759157
pubmed: 34912220
J Ethnopharmacol. 2020 Jan 10;246:112128
pubmed: 31386888
Chin Med. 2020 Aug 26;15:88
pubmed: 32863857
Phytomedicine. 2020 Feb;67:153165
pubmed: 31954259
Phytomedicine. 2018 Jun 1;45:59-67
pubmed: 29685365
Chin Med. 2017 Dec 28;12:36
pubmed: 29299052
Acta Pharm Sin B. 2021 Jan;11(1):222-236
pubmed: 33072499
J Pharm Biomed Anal. 2015;111:277-87
pubmed: 25912849
Environ Pollut. 2019 May;248:874-887
pubmed: 30856503
Phytomedicine. 2018 May 15;44:182-186
pubmed: 29526582
J Pharm Sci. 1998 Jul;87(7):901-3
pubmed: 9649361
Pharmacol Res. 2020 Aug;158:104939
pubmed: 32445956
Front Pharmacol. 2020 Jul 17;11:1066
pubmed: 32848729
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jan 1;1104:59-66
pubmed: 30445288
J Sep Sci. 2006 Nov;29(17):2584-93
pubmed: 17313098

Auteurs

Jiayun Chen (J)

Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.

Xiaojuan Jiang (X)

Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.

Chunyan Zhu (C)

Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.

Lu Yang (L)

College of Pharmacy, Jiamusi University, Jiamusi, China.

Minting Liu (M)

Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.

Mingshe Zhu (M)

Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
MassDefect Technologies, Princeton, NJ, United States.

Caisheng Wu (C)

Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.

Classifications MeSH